Evidence map›Paper›PMID 29127593›Full record

GuidelineClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2018

SEOM clinical guideline for treatment of cancer pain (2017).

C Jara, S Del Barco, C Grávalos, S Hoyos, B Hernández, M Muñoz, T Quintanar, J A Meana, C Rodriguez, R de Las Peñas

Abstract readPractice Guideline
In one paragraph

Guideline in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Management of patients with cancer pain: an evaluation of AGREE II-based clinical practice guidelines.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Pooled it
  2. Cancer pain.Nature reviews. Disease primers · 2026
    Review
  3. Article
  4. Breakthrough cancer pain management (BTcP)-gap analysis of the current Australian landscape.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Differences in cancer pain management between outpatient and inpatient settings: A cross-sectional survey of nursing practices in China.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  6. Neuropathic Pain in Cancer: What Are the Current Guidelines?Current treatment options in oncology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Gabapentinoid Prescribing Practices at a Large Academic Medical Center.Mayo Clinic proceedings. Innovations, quality & outcomes · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

C JaraHospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Madrid, Spain. cjara@fhalcorcon.es.ORCID http://orcid.org/0000-0003-1158-9415
S Del BarcoHospital Universitario Dr. Josep Trueta (ICO), Gerona, Spain.
C GrávalosHospital Universitario, 12 de Octubre, Madrid, Spain.
S HoyosHospital Rey Juan Carlos de Móstoles, Madrid, Spain.
B HernándezComplejo Hospitalario de Navarra, Pamplona, Spain.
M MuñozHospital Virgen de la Luz, Cuenca, Spain.
T QuintanarHospital General Universitario de Elche y Vega Baja, Alicante, Spain.
J A MeanaHospital General Universitario de Alicante, Alicante, Spain.
C RodriguezHospital Universitario de Salamanca, Salamanca, Spain.
R de Las PeñasConsorcio Hospitalario Provincial de Castellón, Castellón de la Plana, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain is a highly prevalent symptom in patients with cancer. Despite therapeutic advances and well-accepted treatment guidelines, a percentage of patients with pain are under-treated. Currently, it has been recognized that several barriers in pain management still exist and, in addition, there are new challenges surrounding complex subtypes of pain, such as breakthrough and neuropathic pain, requiring further reviews and recommendations. This is an update of the guide our society previously published and represents the continued commitment of SEOM to move forward and improve supportive care of cancer patients.

Indexed as

Cancer PainHumansPain ManagementBreakthrough painCancer painCoanalgesicsNeuropathic painOpioids

Identifiers

PMID29127593
PMCPMC5785609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.